Should you buy ESPR stock?

Last updated:

Based on market data through , StockInvest.us rates Esperion Therapeutics (ESPR) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Up 1.92%
  • 3-month trend forecast Up 2.23%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of ESPR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ESPR to Watchlist?
Some Reasons Why To Add ESPR:
  • 99.37% TTM dividend yield
  • +72.4% price growth over the last year
  • Bullish trend confirmed on both short and long timeframes
PDF

Esperion Therapeutics stock price ended at $3.18 on Monday, after losing 0%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since May 04, 2026 Gain 1.92%

No changes to the price of Esperion Therapeutics stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 0% from a day low at $3.18 to a day high of $3.18. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the lower part of a narrow and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.18 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.23% during the next 3 months and, with a 90% probability hold a price between $3.25 and $3.29 at the end of this 3-month period.

ESPR Signals & Forecast

The Esperion Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.18 and $3.17. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -0.313%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Esperion Therapeutics stock

Esperion Therapeutics finds support from accumulated volume at $3.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $3.05 (-4.01%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (ESPR) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Esperion Therapeutics to open at $3.18, and during the day (based on 14 day Average True Range), to move between $3.18 and $3.18, which gives a possible trading interval of +/-$0.0036 (+/-0.11%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 0.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.19 (0.31%) than the support at $3.16 (0.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Esperion Therapeutics stock A Buy?

Esperion Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $3.18 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ESPR Performance

Trading levels for ESPR

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.18 -
R2 3.18 -
R1 3.18 -
Price 3.18
S1 3.18 -
S2 3.18 -
S3 3.18 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 3.19 0.314%
Price 3.18
S1 3.16 -0.629%
S2 3.15 -0.94%
S3 3.13 -1.57%

ESPR Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 13, 2026 Jul 13, 2026 Jul 13, 2026 $3.16 99.06%

FAQ

What is the symbol for Esperion Therapeutics Stock and on which exchange is it traded?
The symbol for Esperion Therapeutics is ESPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Esperion Therapeutics Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Esperion Therapeutics (ESPR) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on May 04, 2026, the price has risen 1.92%. The current 3-month trend forecast projects a rise of 2.23%.

How to buy Esperion Therapeutics Stock?
Esperion Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Esperion Therapeutics Stock.

What's the current price of Esperion Therapeutics Stock?
As of the end of day on the Aug 10, 2026, the price of an Esperion Therapeutics (ESPR) share was $3.18.

What is the 52-week high and low for Esperion Therapeutics Stock?
The 52-week high for Esperion Therapeutics Stock is $4.18 and the 52-week low is $1.74.

What is the market capitalization of Esperion Therapeutics Stock?
As of the Aug 10, 2026, the market capitalization of Esperion Therapeutics is 661.15M.
Click to get the best stock tips daily for free!
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE